Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Israel Cruz

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
BMJ (Clinical Research Ed.)|November 28, 2020
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological studyRoberto Pastor-Barriuso, Beatriz Pérez-Gómez, Miguel A Hernán, et al.
Trials|July 8, 2022
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in BeninRoch Christian Johnson, Emma Sáez-López, Esaï Sèdjro Anagonou, et al.
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Mbio|November 8, 2018
<i>Leishmania</i> Genome Dynamics during Environmental Adaptation Reveal Strain-Specific Differences in Gene Copy Number Variation, Karyotype Instability, and Telomeric AmplificationGiovanni Bussotti, Evi Gouzelou, Mariana Côrtes Boité, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
BMJ (Clinical Research Ed.)|November 28, 2020
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological studyRoberto Pastor-Barriuso, Beatriz Pérez-Gómez, Miguel A Hernán, et al.
Trials|July 8, 2022
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in BeninRoch Christian Johnson, Emma Sáez-López, Esaï Sèdjro Anagonou, et al.
Scientific Reports|October 27, 2022
Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasisPrakash Ghosh, Rajashree Chowdhury, Shomik Maruf, et al.
Mbio|November 8, 2018
<i>Leishmania</i> Genome Dynamics during Environmental Adaptation Reveal Strain-Specific Differences in Gene Copy Number Variation, Karyotype Instability, and Telomeric AmplificationGiovanni Bussotti, Evi Gouzelou, Mariana Côrtes Boité, et al.
Pageof 8